急性阿波辛因-坦多西衍生物 (ATDs) 在大鼠中加剧了甲基胺诱导的超位运动
Takashi Uehara1, Hiroko Itoh2, Hitoshi Abe3
1Department of Neuropsychiatry, Kanazawa Medical University, 1-1 Daigaku, Uchinada- cho, Ishikawa, 920-0293, Japan. uehara@kanazawa-med.ac.jp.
Psychopharmacology
|March 5, 2026
概括
急性给予阿波辛因-坦多西衍生物 (ATDs) 没有显示抗精神病作用,而是增加了甲胺诱导的过度活跃性,与它们的慢性作用不同.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 行为科学 行为科学
背景情况:
- 阿波基尼-坦多西衍生物 (ATDs) 在长期治疗甲基胺 (MAP) 诱导的行为问题方面表现有前途.
- ATD对行为,特别是精神病的急性影响尚不清楚.
研究的目的:
- 在大鼠模型中研究ATDs的急性抗精神病类效应.
- 评估急性ATD给药对MAP诱导的行为异常的影响.
主要方法:
- 大鼠接受了ATD (A-2,A-3,A-4),非典型抗精神病药物或盐水等急性治疗.
- 在中部前额皮质 (mPFC) 和核 (NAC) 中评估了自发和MAP诱导的运动活动,前脉冲抑制 (PPI) 和多巴胺 (DA) 水平.
主要成果:
- 急性ATD的使用并没有减少自发活动或抑制MAP诱导的超位运动.
- 所有测试的ATD都显著增强了MAP诱导的运动器反应,A-3显示了剂量依赖的效果.
- ATDs没有改善MAP诱导的PPI缺陷,DA水平的神经化学变化是最小的.
结论:
- 急性ATD的使用不会产生类似抗精神病药物的效果或抑制MAP诱导的行为异常.
- ATDs急剧增强MAP诱导的运动运动活动,与他们之前观察到的慢性治疗作用分离.
相关概念视频
Adrenergic Agonists: Indirect-Acting Agents
2.9K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.9K
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids
1.0K
CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
1.0K
Drugs Acting on Autonomic Ganglia: Stimulants
2.2K
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
2.2K
Drugs Affecting Neurotransmitter Synthesis
2.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.4K
Stimulants
1.1K
Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
1.1K
Drugs Affecting Neurotransmitter Release or Uptake
1.7K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.7K


